Clinical Trial Update: A Clinical Trial Evaluating the Efficacy, Safety, and Pharmacokinetics of HSK21542 Injection in Liver Disease Subjects With Pruritus [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating HSK21542 injection for pruritus in liver disease completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Disease
• Pruritus

Drugs mentioned

• HSK21542

Snippet

Sponsor: Haisco Pharmaceutical Group Co., Ltd. | Conditions: Pruritus | Phase 2 | Status: COMPLETED